Nimotuzumab in Adults With Glioblastoma Multiforma

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 31, 2007

Study Completion Date

January 31, 2012

Conditions
Adults With Glioblastoma Multiforma
Interventions
DRUG

nimotuzumab

monoclonal antibody

Trial Locations (1)

20246

Dep. Neurosurgery, Univ. Hamburg, Hamburg

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Neurological Clinic, Knappschaftskrankenhaus Bochum-Langendreer, Bochum, Germany

UNKNOWN

collaborator

University of Bonn

OTHER

collaborator

Dep. of Neurosurgery and Policlinic, University Hospital, Dresden, Germany

OTHER

collaborator

Heinrich-Heine University, Duesseldorf

OTHER

collaborator

Johann Wolfgang Goethe University Hospital

OTHER

collaborator

University of Giessen

OTHER

collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

collaborator

University of Kiel

OTHER

collaborator

Dr. von Haunersches Children's Medical Hospital, University of Munich, Germany

OTHER

collaborator

Universität Tübingen

OTHER

lead

Oncoscience AG

INDUSTRY